Vimarsana
Biggest News Aggregation in the World

Page 2 - Tom Plitz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tom Plitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tom Plitz Today - Breaking & Trending Today

Investegate |RELIEF THERAPEUTICS Holdings A Announcements | RELIEF THERAPEUTICS Holdings A: Relief Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG Approved with Large Majority - Vimarsana News

Investegate |RELIEF THERAPEUTICS Holdings A Announcements | RELIEF THERAPEUTICS Holdings A: Relief Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG Approved with Large Majority

RELIEF THERAPEUTICS Holdings A EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): AGMEGM Relief Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG Approved with Large Majority 18.12.2020 / 07:00 RELIEF THERAPEUTICS Holding AG Approved with Large Majority Geneva, Switzerland, December 18, 2020 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (" Relief" or the " Company"), a biopharmaceutical company with its lead compound RLF-100 TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, announces that all agenda ...

Relief Therapeutics Holding AG (via Public) / Relief Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG Approved with Large Majority - Vimarsana News

Relief Therapeutics Holding AG (via Public) / Relief Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG Approved with Large Majority

12/18/2020 | Press release | Distributed by Public on 12/18/2020 00:05 Relief Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG Approved with Large Majority Geneva, Switzerland, December 18, 2020 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ('Relief' or the 'Company'), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, announces that all agenda items of yesterday's Extraordinary General Meeting ('EGM') were approved with a large majority (more than 90 perce...